Objective: Lacunae in literature persist regarding the mechanisms connected with the progression from metabolic syndrome (MetS) to Type 2 diabetes and cardiovascular disease (CVD). To validate heart rate variability (HRV), as a tool for progression of CVD in patients visiting cardiovascular outpatient clinic. Material and Methods: This crosssectional study involved screening of 126 patients for the presence of one or more cardiometabolic risk factors and followed with HRV measurement after categorizing them as MetS+ or control MetS-. Results: Time domain analysis showed a significant reduction between male and female of MetS- and MetS+ While frequency domain analysis in MetS+ male showed no difference, MetS+ female showed significant difference in TP and HF indices. With increasing number of metabolic components, the MetS+ males exhibited significant decrease in the time domain and increase in frequency domain indices of HRV. Body mass index (BMI), waist circumference (WC), high-density lipoprotein (HDL), and triglyceride (TG) were associated with time and frequency domain of HRV among MetS+ and MetS- males and females. Low density lipoprotein (LDL) was a significant predictor of SDNN, RRSSD, and NN50 in patients with MetS+ while HDL was a significant predictor of Standard deviation of normal-to-normal intervals (SDNN) and pNN50. BMI was significant predictor of SDNN and pNN50 in MetS- patients and NN50 in MetS+ patients. In MetS+, the significant predictor of HF was WC, TG, HDL and LDL and that of LF were TG and LDL while in MetS-, WC was significant predictor of LF and HDL of LF/HF. Conclusion: MetS+ females showed lower vagal activity and decreased sympathetic predominance as compared to MetS males suggesting greater cardiovascular risk.
Keywords: Metabolic syndrome; heart rate variability; autonomic dysfunction; cardiovascular disease; insulin resistance; cardiometabolic risks
Amaç: Metabolik sendromdan (MetS) Tip 2 diyabet ve kardiyovasküler hastalığa (KVH) progresyon mekanizmalarına dair literatürdeki eksiklik devam etmektedir. Bu çalışmada, kardiyovasküler poliklinik hastalarında, kalp hızı değişkenliğinin (KHD) kardiyovasküler hastalığın progresyonuna dair bir belirteç olduğunu doğrulamak amaçlanmıştır. Gereç ve Yöntemler: Bu kesitsel çalışmada, 126 hasta bir veya daha fazla kardiyometabolik risk faktörü varlığı açısından taranmış ve MetS+ veya kontrol MetS- olarak kategorize edildikten sonra KHD ölçümü ile takip edilmiştir. Bulgular: Zaman alanı analizi, MetS- ve MetS+ erkek ve kadınlarda TP ve HF indekslerinde önemli bir azalma olduğunu gösterdi. Frekans alanı analizinde, MetS+ erkekte TP ve HF indekslerinde fark izlenmezken, MetS+ kadında anlamlı farklılık görülmüştür. Artan metabolik bileşen sayısıyla birlikte MetS+ erkekler, KHD'nin zaman alanı indeksinde anlamlı bir azalma, frekans alanı indeksinde ise artış göstermiştir. Beden kitle indeksi (BKİ), bel çevresi (BÇ), yüksek dansiteli protein (HDL) ve trigliserid (TG), MetS+ ve MetS- erkek ve kadınlarda KHD'nin zaman ve frekans alanı ile ilişkilendirildi. MetS+ hastalarda düşük yoğunluklu protein (LDL), normal-normal aralıkların standard sapması (SDNN), RRSSD ve NN50 için HDL ise SDNN ve pNN50 için anlamlı bir prediktördü. BMI, MetS- hastalarda SDNN ve pNN50 için MetS+ hastalarda ise NN50 için anlamlı bir prediktördü. MetS+'de BÇ, TG, HDL ve LDL HF için TG ve LDL ise LF için anlamlı prediktörlerdi. MetS-'de BÇ LF için HDL ise LF/HF için anlamlı bir prediktördü. Sonuç: MetS+ kadınlar, MetS erkeklere kıyasla daha düşük vagal aktivite ve azalmış sempatik predominans göstermiştir, bu da kardiyovasküler riskin daha yüksek olduğunu düşündürmüştür.
Anahtar Kelimeler: Metabolik sendrom; kalp hızı değişkenliği; otonom disfonksiyon; kardiyovasküler hastalık; insülin direnci; kardiyometabolik riskler
- Kamath MV, Watanabe MA, Upton ARM. Heart rate variability (HRV) signal analysis: Clinical applications. (2016). (ISBN 9781439849804) [Crossref]
- Gerritsen J, Dekker JM, TenVoorde BJ, Kostense PJ, Heine RJ, Bouter LM, et al. Impaired autonomic function is associated with increased mortality, especially in subjects with diabetes, hypertension, or a history of cardiovascular disease: the Hoorn Study. Diabetes Care. 2001;24(10):1793-8. [Crossref] [PubMed]
- La Rovere MT, Bigger JT Jr, Marcus FI, Mortara A, Schwartz PJ. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet. 1998;351(9101):478-84. [Crossref] [PubMed]
- Tsuji H, Larson MG, Venditti FJ Jr, Manders ES, Evans JC, Feldman CL, et al. Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study. Circulation. 1996;94(11):2850-5. [Crossref] [PubMed]
- Koskinen T, Kähönen M, Jula A, Mattsson N, Laitinen T, Keltikangas-Järvinen L, et al. Metabolic syndrome and short-term heart rate variability in young adults. The cardiovascular risk in young Finns study. Diabet Med. 2009; 26(4):354-61. [Crossref] [PubMed]
- Liao D, Sloan RP, Cascio WE, Folsom AR, Liese AD, Evans GW, et al. Multiple metabolic syndrome is associated with lower heart rate variability. The Atherosclerosis Risk in Communities Study. Diabetes Care. 1998;21(12): 2116-22. [Crossref] [PubMed]
- Min KB, Min JY, Paek D, Cho SI. The impact of the components of metabolic syndrome on heart rate variability: using the NCEP-ATP III and IDF definitions. Pacing Clin Electrophysiol. 2008;31(5):584-91. [Crossref] [PubMed]
- Stein PK, Barzilay JI, Domitrovich PP, Chaves PM, Gottdiener JS, Heckbert SR, et al. The relationship of heart rate and heart rate variability to non-diabetic fasting glucose levels and the metabolic syndrome: the Cardiovascular Health Study. Diabetic Medicine. 2007;24(8): 855-63. [Crossref] [PubMed]
- Carter JB, Banister EW, Blaber AP. The effect of age and gender on heart rate variability after endurance training. Med Sci Sports Exerc. 2003;35(8):1333-40. [Crossref] [PubMed]
- Madden KM, Levy WC, Stratton JK. Exercise training and heart rate variability in older adult female subjects. Clin Invest Med. 2006;29(1): 20-8. [PubMed]
- Meigs JB. The metabolic syndrome. BMJ. 2003;327(7406):61-2. [Crossref] [PubMed] [PMC]
- McKelvie RS, Teo KK, McCartney N, Humen D, Montague T, Yusuf S. Effects of exercise training in patients with congestive heart failure: a critical review. J Am Coll Cardiol. 1995;25(3):789-96. [Crossref] [PubMed]
- Veerabhadrappa SG, Baljoshi VS, Khanapure S, Herur A, Patil S, Ankad RB, et al. Effect of yogic bellows on cardiovascular autonomic reactivity. J Cardiovasc Dis Res. 2011;2(4):223-7. [Crossref] [PubMed] [PMC]
- Alberti KG, Zimmet P, Shaw J; IDF Epidemiology Task Force Consensus Group. The metabolic syndrome--a new worldwide definition. Lancet. 2005;366(9491):1059-62. [Crossref] [PubMed]
- Yin J, Li M, Xu L, Wang Y, Cheng H, Zhao X, et al. Insulin resistance determined by Homeostasis Model Assessment (HOMA) and associations with metabolic syndrome among Chinese children and teenagers. Diabetol Metab Syndr. 2013;5(1):71. [Crossref] [PubMed] [PMC]
- Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation. 1996;93(5):1043-65. [PubMed]
- Stein PK, Kleiger RE. Insights from the study of heart rate variability. Annu Rev Med. 1999;50:249-61. [Crossref] [PubMed]
- Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998; 15(7):539-53. [Crossref] [PubMed]
- Alberti KG, Zimmet P, Shaw J. Metabolic syndrome--a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med. 2006;23(5): 469-80. [Crossref] [PubMed]
- Kang MG, Koh SB, Cha BS, Park JK, Woo JM, Chang SJ. Association between job stress on heart rate variability and metabolic syndrome in shipyard male workers. Yonsei Med J. 2004;45(5):838-46. [Crossref] [PubMed]
- Stuckey MI, Kiviniemi A, Gill DP, Shoemaker JK, Petrella RJ. Associations between heart rate variability, metabolic syndrome risk factors, and insulin resistance. Appl Physiol Nutr Metab. 2015;40(7):734-40. [Crossref] [PubMed]
- Min JY, Paek D, Cho SI, Min KB. Exposure to environmental carbon monoxide may have a greater negative effect on cardiac autonomic function in people with metabolic syndrome. Sci Total Environ. 2009;407(17):4807-11. [Crossref] [PubMed]
- Assoumou HG, Pichot V, Barthelemy JC, Dauphinot V, Celle S, Gosse P, et al. Metabolic syndrome and short-term and long-term heart rate variability in elderly free of clinical cardiovascular disease: the PROOF study. Rejuvenation Res. 2010;13(6):653-63. [Crossref] [PubMed]
- Brunner EJ, Hemingway H, Walker BR, Page M, Clarke P, Juneja M, et al. Adrenocortical, autonomic, and inflammatory causes of the metabolic syndrome: nested case-control study. Circulation. 2002;106(21):2659-65. [Crossref] [PubMed]
- Kishi T, Hirooka Y, Konno S, Sunagawa K. Angiotensin II receptor blockers improve endothelial dysfunction associated with sympathetic hyperactivity in metabolic syndrome. J Hypertens. 2012;30(8):1646-55. [Crossref] [PubMed]
- Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al; International Diabetes Federation Task Force on Epidemiology and Prevention; Hational Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640-5. [Crossref] [PubMed]
- Laaksonen DE, Laitinen T, Schönberg J, Rissanen A, Niskanen LK. Weight loss and weight maintenance, ambulatory blood pressure and cardiac autonomic tone in obese persons with the metabolic syndrome. J Hypertens. 2003; 21(2):371-8. [Crossref] [PubMed]
- Jarczok MN, Li J, Mauss D, Fischer JE, Thayer JF. Heart rate variability is associated with glycemic status after controlling for components of the metabolic syndrome. Int J Cardiol. 2013;167(3):855-61. [Crossref] [PubMed]
- Gehi AK, Lampert R, Veledar E, Lee F, Goldberg J, Jones L, et al. A twin study of metabolic syndrome and autonomic tone. J Cardiovasc Electrophysiol. 2009;20(4):422-8. [Crossref] [PubMed] [PMC]
.: Process List